Home

 Company Profile News & Events Scientific Programme Licensing AIM Rule 26 Feedback Contact Us
 
 

Pharmaceutical Products

          Pharmaceutical- Ionic Contra Viral Therapy (ICVT)
  Overview
Formulation Studies
Ophthalmic Disease
Skin Warts And Verrucae (Plantar Warts)
Genital Warts
Herpes And Dysplastic Disease
Recurrent Respiratory Papilloma
Animal Health
Other
 
   
Biological Products
  Biologics
Overview of Biologics
• Preps And L-Particles
   o Simple Description
   o More Complex Description
      • Overview
      • Herpes Simplex Vaccine
      • Other Herpes Virus Vaccine
      • Cancer Immunotherapeutic
      • Other Uses
         o Stem cell study

Koi Herpes Vaccine
 
 
 
 

Biologics

Cytomegalovirus CMV
Cytomegalovirus infection is exceedingly common- in most individuals with a healthy immune system, the disease is very minor and does not cause significant or dangerous symptoms. In those individuals with an impaired immunity (such as organ transplant recipients who are taking immunosuppressant drugs) the virus can cause life-threatening infections.
The structure of CMV is similar to that of herpes simplex, and antigenic glycoproteins from CMV have successfully been engineered, expressed and delivered to cells by L-particles. Pre-clinical studies are ongoing to examine this application of the technology.

Next: Cancer Immunotherapeutic
 

 

Home | Company Profile  | News & Events  | Scientific Programme | Licensing  | Investor Relations  | Feedback  | Contact Us